Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASTRA
NCT07368959Phase 3Active, not recruiting
- Sponsor
- Aurion Biotech
- Start
- Feb 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules, Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of AURN001 in corneal edema, corneal endothelial dysfunction, sponsored by Aurion Biotech. Started Feb 2026; status: active, not recruiting.
02
Drugs
AURN001
03
Conditions
corneal edemacorneal endothelial dysfunction
Beyond the preview
Go deeper on NCT07368959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07368959.